Old Web
English
Sign In
Acemap
>
authorDetail
>
Yara Nasser
Yara Nasser
Medicine
Internal medicine
Endocrinology
Pediatrics
Trough level
5
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with Adalimumab.
2020
Journal of Clinical Medicine
Mohamad Cherry
Dominique Dutzer
Yara Nasser
A E Berger
Xavier Roblin
Stephane Paul
Show All
Source
Cite
Save
Citations (5)
Accidental apixaban intoxication in a 23-month-old child: a case report.
2020
BMC Pediatrics
Manon Launay
Yara Nasser
Isabelle Maubert
Anne-Cécile Chaux
Xavier Delavenne
Show All
Source
Cite
Save
Citations (0)
Delaying Centrifugation and Freezing by Adding a DPD Inhibitor such as Gimeracil to Blood Sample is not a Valid Option to Simplify the Preanalytic Step for the Screening of Dihydropyrimidine Dehydrogenase (DPD) Deficiency Induced by Uracilemia.
2019
Therapeutic Drug Monitoring
Manon Launay
Yara Nasser
Yannick Tholance
Sandrine Dellinger
Philippe Gonzalo
Xavier Delavenne
Show All
Source
Cite
Save
Citations (0)
Peser les patients habillés induit un risque de surestimation de leur statut nutritionnel
2018
Nutrition Clinique Et Metabolisme
Yara Nasser
Philippe Fayemendy
Manon Arnal
H. Sourisseau
S. Bonhommo
Jean-Claude Desport
Béatrice Morin
Pierre Jésus
Show All
Source
Cite
Save
Citations (0)
Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
2018
Digestive Diseases and Sciences
Yara Nasser
Rémi Labetoulle
Inès Harzallah
Anne-Emmanuelle Berger
Xavier Roblin
Stephane Paul
Show All
Source
Cite
Save
Citations (16)
1